CENPR_HUMAN - dbPTM
CENPR_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CENPR_HUMAN
UniProt AC Q13352
Protein Name Centromere protein R
Gene Name ITGB3BP
Organism Homo sapiens (Human).
Sequence Length 177
Subcellular Localization Isoform 1: Nucleus. Chromosome, centromere. Chromosome, centromere, kinetochore.
Isoform 2: Nucleus.
Isoform 3: Nucleus. Cytoplasm. Isoform 3 is predominantly nuclear and weakly cytoplasmic.
Isoform 4: Cytoplasm.
Protein Description Transcription coregulator that can have both coactivator and corepressor functions. Isoform 1, but not other isoforms, is involved in the coactivation of nuclear receptors for retinoid X (RXRs) and thyroid hormone (TRs) in a ligand-dependent fashion. In contrast, it does not coactivate nuclear receptors for retinoic acid, vitamin D, progesterone receptor, nor glucocorticoid. Acts as a coactivator for estrogen receptor alpha. Acts as a transcriptional corepressor via its interaction with the NFKB1 NF-kappa-B subunit, possibly by interfering with the transactivation domain of NFKB1. Induces apoptosis in breast cancer cells, but not in other cancer cells, via a caspase-2 mediated pathway that involves mitochondrial membrane permeabilization but does not require other caspases. May also act as an inhibitor of cyclin A-associated kinase. Also acts a component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex..
Protein Sequence MPVKRSLKLDGLLEENSFDPSKITRKKSVITYSPTTGTCQMSLFASPTSSEEQKHRNGLSNEKRKKLNHPSLTESKESTTKDNDEFMMLLSKVEKLSEEIMEIMQNLSSIQALEGSRELENLIGISCASHFLKREMQKTKELMTKVNKQKLFEKSTGLPHKASRHLDSYEFLKAILN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MPVKRSLKLDGLL
--CCCCCCCCCCCHH
24.9221712546
8SumoylationMPVKRSLKLDGLLEE
CCCCCCCCCCCHHCC
45.86-
8UbiquitinationMPVKRSLKLDGLLEE
CCCCCCCCCCCHHCC
45.86-
8SumoylationMPVKRSLKLDGLLEE
CCCCCCCCCCCHHCC
45.8628112733
17PhosphorylationDGLLEENSFDPSKIT
CCHHCCCCCCHHHCC
34.0125159151
18 (in isoform 5)Phosphorylation-27.8224719451
18PhosphorylationGLLEENSFDPSKITR
CHHCCCCCCHHHCCC
27.8224719451
21PhosphorylationEENSFDPSKITRKKS
CCCCCCHHHCCCCCE
38.2426074081
22SumoylationENSFDPSKITRKKSV
CCCCCHHHCCCCCEE
54.1828112733
22UbiquitinationENSFDPSKITRKKSV
CCCCCHHHCCCCCEE
54.18-
27MethylationPSKITRKKSVITYSP
HHHCCCCCEEEEECC
46.82-
28PhosphorylationSKITRKKSVITYSPT
HHCCCCCEEEEECCC
23.0630266825
31PhosphorylationTRKKSVITYSPTTGT
CCCCEEEEECCCCCE
18.7830266825
32PhosphorylationRKKSVITYSPTTGTC
CCCEEEEECCCCCEE
11.0930266825
33PhosphorylationKKSVITYSPTTGTCQ
CCEEEEECCCCCEEE
13.7130266825
35PhosphorylationSVITYSPTTGTCQMS
EEEEECCCCCEEEEE
31.7330266825
36PhosphorylationVITYSPTTGTCQMSL
EEEECCCCCEEEEEE
33.6030266825
38PhosphorylationTYSPTTGTCQMSLFA
EECCCCCEEEEEEEE
9.4730266825
42PhosphorylationTTGTCQMSLFASPTS
CCCEEEEEEEECCCC
8.4130266825
46PhosphorylationCQMSLFASPTSSEEQ
EEEEEEECCCCHHHH
22.7530266825
48PhosphorylationMSLFASPTSSEEQKH
EEEEECCCCHHHHHH
42.2530266825
49PhosphorylationSLFASPTSSEEQKHR
EEEECCCCHHHHHHH
38.8530266825
50PhosphorylationLFASPTSSEEQKHRN
EEECCCCHHHHHHHC
47.8630266825
56PhosphorylationSSEEQKHRNGLSNEK
CHHHHHHHCCCCHHH
46.0427251275
60PhosphorylationQKHRNGLSNEKRKKL
HHHHCCCCHHHHHHC
44.3220860994
66SumoylationLSNEKRKKLNHPSLT
CCHHHHHHCCCCCCC
59.56-
66UbiquitinationLSNEKRKKLNHPSLT
CCHHHHHHCCCCCCC
59.56-
66SumoylationLSNEKRKKLNHPSLT
CCHHHHHHCCCCCCC
59.56-
71PhosphorylationRKKLNHPSLTESKES
HHHCCCCCCCCCCCC
40.1310490654
72PhosphorylationKKLNHPSLTESKEST
HHCCCCCCCCCCCCC
7.8924719451
73PhosphorylationKLNHPSLTESKESTT
HCCCCCCCCCCCCCC
42.4228450419
74PhosphorylationLNHPSLTESKESTTK
CCCCCCCCCCCCCCC
66.1727251275
75PhosphorylationNHPSLTESKESTTKD
CCCCCCCCCCCCCCC
36.1723186163
76UbiquitinationHPSLTESKESTTKDN
CCCCCCCCCCCCCCH
49.83-
81UbiquitinationESKESTTKDNDEFMM
CCCCCCCCCHHHHHH
55.40-
92SumoylationEFMMLLSKVEKLSEE
HHHHHHHHHHHHHHH
55.15-
92UbiquitinationEFMMLLSKVEKLSEE
HHHHHHHHHHHHHHH
55.15-
92SumoylationEFMMLLSKVEKLSEE
HHHHHHHHHHHHHHH
55.15-
126PhosphorylationLENLIGISCASHFLK
HHHHHHHHHHHHHHH
9.8320068231
129PhosphorylationLIGISCASHFLKREM
HHHHHHHHHHHHHHH
21.0620068231
133UbiquitinationSCASHFLKREMQKTK
HHHHHHHHHHHHHHH
45.42-
154UbiquitinationNKQKLFEKSTGLPHK
HHHHHHHHHHCCCCH
46.08-
155PhosphorylationKQKLFEKSTGLPHKA
HHHHHHHHHCCCCHH
22.1027251275
156PhosphorylationQKLFEKSTGLPHKAS
HHHHHHHHCCCCHHH
54.5327251275
161UbiquitinationKSTGLPHKASRHLDS
HHHCCCCHHHHCCCH
46.23-
163PhosphorylationTGLPHKASRHLDSYE
HCCCCHHHHCCCHHH
25.6527251275
168PhosphorylationKASRHLDSYEFLKAI
HHHHCCCHHHHHHHH
32.6820068231
169PhosphorylationASRHLDSYEFLKAIL
HHHCCCHHHHHHHHH
15.4629496907
172 (in isoform 5)Ubiquitination-2.15-
173UbiquitinationLDSYEFLKAILN---
CCHHHHHHHHHC---
38.41-
195Phosphorylation-------------------------
-------------------------
27251275
207Phosphorylation-------------------------------------
-------------------------------------
27251275
208Phosphorylation--------------------------------------
--------------------------------------
27251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
28SPhosphorylationKinasePAK1Q13153
PSP
33SPhosphorylationKinaseCDK2P24941
PSP
46SPhosphorylationKinaseCDK2P24941
PSP
-KUbiquitinationE3 ubiquitin ligaseTRAF6Q9Y4K3
PMID:16252010

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CENPR_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CENPR_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ARFP2_HUMANARFIP2physical
16189514
THA_HUMANTHRAphysical
11713274
RXRG_HUMANRXRGphysical
11713274
CENPR_HUMANITGB3BPphysical
11713274
NFKB1_HUMANNFKB1physical
12244126
TF65_HUMANRELAphysical
12244126
CCNA2_HUMANCCNA2physical
10673397
RXRA_HUMANRXRAphysical
10490654
THA_HUMANTHRAphysical
10490654
ITB5_HUMANITGB5physical
10579726
MTA1_HUMANMTA1physical
15254226
ACTN2_HUMANACTN2physical
15604093
A4_HUMANAPPphysical
21832049
KDM1A_HUMANKDM1Aphysical
23455924
ARFP2_HUMANARFIP2physical
25416956
UBR7_HUMANUBR7physical
25416956
PIHD2_HUMANPIH1D2physical
25416956
CENPU_HUMANCENPUphysical
26186194
CENPQ_HUMANCENPQphysical
26186194
ATP5J_HUMANATP5Jphysical
26496610
FACD2_HUMANFANCD2physical
26496610
FLNB_HUMANFLNBphysical
26496610
CENPI_HUMANCENPIphysical
26496610
MCM5_HUMANMCM5physical
26496610
COG1_HUMANCOG1physical
26496610
ATPK_HUMANATP5J2physical
26496610
C2CD5_HUMANC2CD5physical
26496610
C43BP_HUMANCOL4A3BPphysical
26496610
COBL1_HUMANCOBLL1physical
26496610
PKN3_HUMANPKN3physical
26496610
CAB45_HUMANSDF4physical
26496610
PPHLN_HUMANPPHLN1physical
26496610
CENPN_HUMANCENPNphysical
26496610
UBE2O_HUMANUBE2Ophysical
26496610
CENPK_HUMANCENPKphysical
26496610
CENPO_HUMANCENPOphysical
26496610
CENPU_HUMANCENPUphysical
26496610
CENPT_HUMANCENPTphysical
26496610
CENPP_HUMANCENPPphysical
26496610
CENPQ_HUMANCENPQphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CENPR_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND MASSSPECTROMETRY.

TOP